Notice of Annual General Meeting

MACFARLANE GROUP

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

If you are in any doubt as to what action you should take, you are recommended to seek your own financial advice from your stockbroker or other independent adviser authorised under the Financial Services and Markets Act 2000.

If you have sold or transferred all of your shares in Macfarlane Group PLC, please forward this document, together with the accompanying documents, as soon as possible either to the purchaser or transferee or to the person who arranged the sale or transfer so they can pass these documents to the person who now holds the shares.

30 March 2022

Dear Shareholder

Macfarlane Group PLC 2022 Notice of Annual General Meeting

This year's Annual General Meeting ('AGM') is to be held at the DoubleTree by Hilton Hotel Glasgow Central, 36 Cambridge Street, Glasgow G2 3HN on 10 May 2022 at 12 noon. This may be subject to review if Covid rules change, however it is our fervent hope that we are able to conduct a traditional AGM this year.

The Board places a high value on the opportunity to meet shareholders at its AGM. However, if you are unable to attend and wish to submit questions at the AGM, please do so by emailing your question to the following email address: [email protected]. This can be done anytime up until 10am on the morning of the AGM to allow the Board to consider these questions during the meeting.

The notice of the AGM, which follows this letter, sets out the business to be considered at the meeting.

The notice also contains items of business which are of a technical nature and these items are explained in more detail on pages 4 to 5.

Your Directors believe that all the proposed resolutions (the 'Resolutions') to be considered at the AGM are in the best interests of the Company and its members as a whole and are most likely to promote the success of the Company for the benefit of its members as a whole. The Directors unanimously recommend that you vote in favour of all the Resolutions as they intend to do in respect of their own beneficial holdings.

I hope that you can attend the AGM on 10 May 2022 should Covid rules allow.

Yours faithfully

Stuart R. Paterson

Chairman

Notice of Annual General Meeting

Macfarlane Group PLC (Company No: SC4221)

NOTICE IS HEREBY GIVEN THAT the one hundred and twenty-first ANNUAL GENERAL MEETING ('AGM') of the members of MACFARLANE GROUP PLC (the 'Company') will be held at the DoubleTree by Hilton Hotel Glasgow Central, 36 Cambridge Street, Glasgow G2 3HN on 10 May 2022 at 12 noon for the purpose of transacting the following business:

Ordinary Business

To consider and, if thought fit, pass the following Resolutions which will be proposed as ordinary resolutions:

To receive, consider and adopt the Directors' Report and the Company's Annual Accounts for the financial year ended 31 December 2021 (the 'Annual Accounts');
To approve the Directors' Remuneration Report for the financial year ended 31 December 2021 set out on pages 46 to 55 (inclusive) in the Annual Accounts;
To approve the Directors' Remuneration Policy for the three-year period from 2022, set out on pages 56 to 62 (inclusive) in the Annual Accounts;
To approve the Macfarlane Group Deferred Bonus Share Plan ('DBSP') (and the Directors be authorised to make any modifications or amendments and to do all such acts and things as they may consider appropriate to implement the DBSP);
To declare a dividend of 2.33p per share payable on 1 June 2022 to shareholders on the register at 6pm on 13 May 2022;
To re-elect Stuart R. Paterson as a Director of the Company;
To re-elect Peter D. Atkinson as a Director of the Company;
To re-elect Ivor Gray as a Director of the Company;
To re-elect Robert McLellan as a Director of the Company;
To re-elect James W.F Baird as a Director of the Company;
To elect Aleen Gulvanessian as a Director of the Company;
To reappoint Deloitte LLP as the Company's auditors to hold office from the conclusion of this meeting until the conclusion of the next general meeting at which accounts are laid before the Company;
To authorise the Directors to determine the remuneration of the auditors.

Special Business

To consider and, if thought fit, pass Resolution 14 which will be proposed as an ordinary Resolution, and Resolutions 15 and 16, which will be proposed as special resolutions:

THAT, in accordance with section 551 of the Companies Act 2006 (the 'Act'), the Directors be generally and unconditionally authorised to allot Relevant Securities (as defined below):

(A) comprising equity securities (as defined by section 560 of the Act) up to an aggregate nominal amount of £13,151,000 (representing one third of the Company's issued share capital as at 1 April 2022) (such amount to be reduced by the nominal amount of any Relevant Securities allotted pursuant to the authority in paragraph (B) below) in connection with an offer by way of a rights issue: (i) to holders of ordinary shares in proportion (as nearly as may be practicable) to their respective holdings; and (ii) to holders of other equity securities as required by the rights of those securities or as the Directors otherwise

consider necessary but subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to treasury shares, fractional entitlements, record dates, legal or practical problems in or under the laws of any territory or the requirements of any regulatory body or stock exchange; and

(B) in any other case, up to an aggregate nominal amount of £3,945,300 (representing 10% of the Company's issued share capital as at 1 April 2022) (such amount to be reduced by the nominal amount of any equity securities allotted pursuant to the authority in paragraph (A) above in excess of the nominal amount of £9,205,700),

provided that this authority shall, unless renewed, varied or revoked by the Company, expire at the end of the next annual general meeting of the Company (or, if earlier, at 5pm on 11 August 2022) save that the Company may, before such expiry, make offers or agreements which would or might require Relevant Securities to be allotted and the Directors may allot Relevant Securities in pursuance of such offer or agreement notwithstanding that the authority conferred by this resolution has expired.

In this resolution, 'Relevant Securities' means shares in the Company, other than shares allotted pursuant to:

an employee share scheme (as defined in section 1166 of the Act);
a right to subscribe for shares in the Company where the grant of the right itself constitutes a Relevant Security; or
a right to convert securities into shares in the Company where the grant of the right itself constitutes a Relevant Security; and
any right to subscribe for or to convert any security into shares in the Company other than rights to subscribe for or convert any security into shares allotted pursuant to an employee share scheme (as defined in section 1166 of the Act). References to the allotment of Relevant Securities in this resolution include the grant of such rights; and 'Relevant Security' shall be any of the Relevant Securities.

This resolution revokes and replaces all unexercised authorities previously granted to the Directors to allot Relevant Securities but without prejudice to any allotment of shares or grant of rights already made, offered or agreed to be made pursuant to such authorities.

THAT if Resolution 14 is passed, the Directors be and are hereby authorised, to allot equity securities (as defined in Resolution 14 for cash under the authority given by that Resolution and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the Act (as defined in resolution 14 did not apply to any such allotment or sale, such authority to be limited:

(A) to allotments for rights issues and other pre-emptive issues; and
(B) to the allotment of equity securities or sale of treasury shares (other than under paragraph (A) above) up to an aggregate nominal amount of £1,972,650 (representing 5% of the Company's issued share capital as at 1 April 2022),

such authority to expire at the end of the next annual general meeting of the Company

(or, if earlier, at 5pm on 10 August 2023) but, in each case, prior to its expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.

Notice of Annual General Meeting (continued)

Macfarlane Group PLC (Company No: SC4221)

THAT if Resolution 14 is passed, the Directors be and are hereby authorised, in addition to any authority granted under Resolution 15 to allot equity securities (as defined in Resolution 14 for cash under the authority given by Resolution 14 and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the Act (as defined in Resolution 14) did not apply to any such allotment or sale, such authority to be:

(A) limited to the allotment of equity securities or the sale of treasury shares up to an aggregate nominal amount of £1,972,650 (representing 5% of the Company's issued share capital as at 1 April 2022); and

(B) used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) a transaction which the Board of the Company determines to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice,

such authority to expire at the end of the next annual general meeting of the Company (or, if earlier, at 5pm on 10 August 2023) but, in each case, prior to its expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.

To transact such other ordinary business as may be properly transacted at the AGM.

By Order of the Board

James Macdonald
Company Secretary
3 Park Gardens
Glasgow G3 7YE
2 April 2022

Explanation of the Resolutions to be proposed at the AGM

Resolution 1 is a standard resolution. The Annual Accounts are required to be laid before the Company in general meeting. The Annual Accounts are accompanied by the Directors' Report, the Directors' Remuneration Report and the report of the Independent Auditor.

Resolution 2 requests approval for the Directors' Remuneration Report, on pages 46 to 55 of the Annual Accounts (the 'Directors' Remuneration Report'). This is an advisory vote and votes cast against approval of the Directors' Remuneration Report will not invalidate the Annual Report and Accounts as a whole and the Directors' entitlement to remuneration is not conditional on it.

Resolution 3 requests approval for the Directors' Remuneration Policy, on pages 56 to 62 of the Annual Accounts (the 'Directors' Remuneration Policy'). This is an advisory vote and votes cast against approval of the Directors' Remuneration Policy will not invalidate the Annual Report and Accounts as a whole and the Directors' entitlement to remuneration is not conditional on it.

Resolution 4 is a resolution seeking authority from shareholders to approve the Macfarlane Group Deferred Bonus Share Plan ('DBSP'). As further described in the Directors' Remuneration Report for 2021, this will enable the deferral of annual bonuses otherwise payable to an Executive Director, into awards over shares that will vest after a 2 year deferral period.

The rules of the DBSP will be on display at the registered office until the AGM and at the place of the AGM for at least 15 minutes beforehand. They are also available for inspection at these times at the offices of FIT Remuneration Consultants LLP, 1 Duke Street, London W1U 3EA.

A summary of the principal terms of the DBSP is set out at Appendix 1 to this notice.

Resolution 5 will, if passed, approve the payment of a final dividend. The Directors have proposed a final dividend of 2.33p per share, to be paid on 1 June 2022 to shareholders on the register at 6pm on 13 May 2022.

Resolutions 6 to 11 inclusive seek approval for the re-appointment of Directors in accordance with the Company's articles of association and the UK Corporate Governance Code as it applies to companies outside the FTSE350. All Directors are retiring and submitting themselves for re-election in accordance with the provisions on retirement by rotation of the Company's articles of association.

The biographies of the Directors seeking re-election or election which appear in the Annual Accounts are repeated here for ease of reference:

Stuart R. Paterson: Stuart joined the Board on 1 January 2013 as a non-executive Director, becoming Chairman on 29 September 2017. He is a Chartered Accountant and was Chief Financial Officer at Forth Ports Limited until he retired in January 2018. He joined Forth Ports in March 2011 when it was listed on the London Stock Exchange and the company was subsequently acquired by Arcus Infrastructure Partners in 2011. Prior to this role, Stuart was Chief Financial Officer of Johnston Press PLC from 2001 to 2010 and previously worked in senior financial management roles at Motorola Corporation, and as Group Finance Director and then Managing Director Europe for Aggreko PLC. Stuart joined Angel Trains Group Limited as a non-executive Director in September 2018, and chairs the Audit & Risk Committee. He is also a trustee of the Royal Yacht Britannia and a member of their Audit, Risk and Remuneration Committees. He also served as a non-executive Director with Devro PLC from 2006 to 2012, chairing the Audit Committee. He chairs the Nominations Committee and is a member of the Remuneration Committee.

Peter D. Atkinson: Peter joined Macfarlane Group as Chief Executive in October 2003. He has a strong sales and marketing background through his career at Procter & Gamble and S.C. Johnson. Peter also has significant general management experience gained during his time at GKN PLC and its joint venture partners where he worked from 1988 to 2001 in a number of senior executive roles in their business-to-business operations. He has a successful track record of both business turnarounds and business development with extensive exposure to international business, having worked in the UK, Europe and the USA.

Explanation of the Resolutions to be proposed at the AGM (continued)

Ivor Gray: Ivor is a member of The Institute of Chartered Accountants of Scotland and has been with the Group for twenty-four years and was appointed Finance Director on 01 January 2021. He has worked in a variety of financial and commercial roles at Macfarlane including Finance Director of Macfarlane Labels; General Manager of Macfarlane USA and Commercial Director of Macfarlane Packaging Distribution. He previously undertook his accountancy training at KPMG prior to joining Macfarlane.

Bob McLellan: Bob joined the Board on 5 March 2013. He was Chief Executive of DS Smith Packaging UK until 2011, latterly as Deputy CEO Packaging (UK and Continental Europe). Bob has spent many years working in the packaging sector and has held leading roles in both the UK and Continental Europe for industry employer associations. He is currently Chairman of the Logson Group and a non-executive director of Swanline Print Limited. Bob chaired the Remuneration Committee until 31 August 2018 when he was appointed as the Group's Senior Independent Director. He is a member of the Nominations, Remuneration and Audit Committees.

James Baird: James joined the Board on 8 January 2018. James previously led the Scotland and Northern Ireland business of Deloitte, the global accountancy firm, before becoming Managing Partner of its Audit & Risk Advisory division and Chief Operating Officer, both in Switzerland. An experienced auditor and advisor who has worked with companies in the UK and Europe across a range of industries, he is currently an Honorary Professor at Glasgow University's Adam Smith Business School. James is a member of both the Research Panel and the Technology Advisory Group of the Institute of Chartered Accountants of Scotland. James was appointed as chair of the Audit Committee on his appointment on 8 January 2018 and is a member of the Remuneration and Nominations Committees.

Aleen Gulvanessian: Aleen joined the Board on 1 October 2021. Aleen was a corporate partner at Eversheds Sutherland for 30 years before stepping down in May 2019 to become a Consultant on Boards and Governance matters. Aleen is an experienced corporate lawyer who has advised private and quoted UK companies (including cross border transactions) across a range of sectors. Her areas of focus have been mergers and acquisitions, joint ventures, corporate finance transactions and reorganisations, as well as general boardroom and governance advice for quoted companies. Aleen is a member of the Governance Committee of the Institute of Chartered Accountants in England and Wales, to which she was appointed in June 2019.

The Board recommends these re-elections and election as they bring significant and relevant expertise to the Board.

Resolution 12 proposes the reappointment of Deloitte LLP as auditors of the Company. The Act requires that auditors be appointed at each general meeting at which accounts are laid to hold office until the next such meeting.

Resolution 13 seeks separate authority for the Directors to determine the remuneration of the auditors of the Company.

Resolution 14 – under the Act the Directors may only allot unissued shares if authorised to do so by the Shareholders in general meeting. At the annual general meeting held in 2021, Shareholders granted the Directors authority to allot relevant securities under Section 551 of the Act for a period of up to 15 months and this authority expires at the 2022 AGM. Resolution 14 seeks to renew this authority to allow the Directors:

(i) to allot shares or grant rights to subscribe for or convert any security into shares up to an aggregate nominal amount of £13,151,000 representing an amount equal to one-third of the Company's issued share capital as at 1 April 2022 (being the latest practicable date before the date of this notice (the 'Latest Practicable Date')) in connection with an offer by way of a rights issue; and

(ii) in any case other than a rights issue to allot Relevant Securities up to an aggregate nominal amount of £3,945,300 (with the nominal amount authorised in B of Resolution 10 to be reduced in the event that Relevant Securities with a nominal value of more than £9,205,700 have been issued in connection with a rights issue pursuant to A of resolution 14 so that the Directors have the authority to allot Relevant Securities with an aggregate nominal value of no more than £13,151,000).

As at 1 April 2022 the Company holds no treasury shares. If given, these authorities will expire at the end of the annual general meeting held in 2023 or at 5pm on 10 August 2023, whichever is the earlier. This authority complies with the latest institutional guidelines issued by the Investment Association.

Resolutions 15 and 16 are proposed as special resolutions, each requiring a majority of 75% of those voting to be in favour. If the Directors wish to allot equity securities for cash they are required by the Act to offer those equity securities first to current shareholders in proportion to their existing holdings.

In certain circumstances, it may be in the best interests of the Company to allot equity securities for cash without first offering them proportionately to existing shareholders. In accordance with the Act and investor guidelines, therefore, approval is sought by the Directors to issue a limited number of ordinary shares for cash without first offering them to existing shareholders.

Resolution 15 contains a two-part disapplication of pre-emption rights which seeks to renew the Directors' authority to issue equity securities of the Company for cash without application of pre-emption rights pursuant to section 561 of the CA 2006. This resolution requests authority for disapplication of statutory pre-emption rights and such authority would be limited to allotments in connection with pre-emptive offers and offers to holders of other equity securities if required by the rights of those shares or as the Board otherwise considers necessary, or otherwise up to an aggregate nominal amount of £3,945,300, representing 10% of the issued share capital of the Company as at the Latest Practicable Date. The authority, if granted, would replace a similar resolution passed at last year's AGM.

Resolution 16 is a disapplication of pre-emption rights limited to an additional 5% of issued ordinary share capital to be used for transactions which the Directors determine to be an acquisition or specified capital investment. The authority contained in the resolution would be limited to a maximum nominal amount of £1,972,650 (representing 5% of the Company's issued share capital as at the Latest Practicable Date).

If given, this power will expire at 5pm on 10 August 2023 or at the conclusion of the annual general meeting held in 2023, whichever is the earlier. The aggregate figure of 10% in resolutions 13 and 14 reflects the Pre-Emption Group 2015 Statement of Principles for the disapplication of pre-emption rights (the 'Statement of Principles').

The Directors will have due regard to the Statement of Principles in relation to any exercise of this power, in particular they do not intend to allot shares for cash on a non pre-emptive basis pursuant to this power:

(i) in excess of an amount equal to 5% of the total issued ordinary share capital of the Company excluding treasury shares; or
(ii) in excess of an amount equal to 7.5% of the total issued ordinary share capital of the Company excluding treasury shares in any rolling three-year period, without prior consultation with shareholders,

in each case other than in connection with an acquisition or specified capital investment (within the meaning of the Statement of Principles) which is announced contemporaneously with the allotment or which has taken place in the preceding six-month period and is disclosed in the announcement of the allotment.

Attendance at AGM and proxy voting

A member entitled to attend and vote at the AGM is entitled to appoint another person as his proxy to exercise all or any of his rights to attend, speak and to vote at the AGM.

A proxy need not be a member of the Company.

A member may appoint more than one proxy provided that each proxy is appointed to exercise the rights attached to a different share or shares held by him. If you wish to appoint more than one proxy please contact the Company's Registrars at the address given below.

A member attending the AGM has the right to ask questions relating to the business being dealt with at the AGM in accordance with section 319A of the Companies Act 2006 (the 'Act'). In certain circumstances prescribed by the same section of the Act, the Company need not answer a question.
Information regarding the AGM, including the information required by section 311A of the Act, is available from www.macfarlanegroup.com.
A form of proxy is enclosed with this notice. (Please note that this is different to the alternative method of submitting proxies using CREST which is described in Note 5 below). To be effective the instrument appointing a proxy must be completed and deposited, together with the authority (if any) under which it is executed or a notarially certified copy of such authority, at the office of the Company's registrars, Equiniti Limited, Aspect House, Spencer Road, Lancing, BN99 8LU (the 'Company's Registrars') not later than forty eight hours (disregarding any day that is not a working day) before the time appointed for holding the AGM, being 12 noon on Friday 6 May 2022.

Completion and return of the form of proxy does not preclude a member from attending and voting in person at the AGM. To change your proxy instructions simply submit a new proxy appointment using the methods set out above. A replacement proxy form may be obtained by contacting the Company.

To revoke your proxy instructions, please contact the Company's Registrars by no later than 12 noon on Friday 6 May 2022. However, if you have appointed a proxy and attend and vote at the AGM in person, your proxy appointment will automatically be terminated when you exercise your vote. If you are not a member of the Company but you have been nominated by a member of the Company to enjoy information rights, you do not have a right to appoint any proxies under the procedures set out in this notice. Please read note 6 relating to nominated persons below.

CREST members who wish to appoint a proxy or proxies by utilising the CREST electronic proxy appointment service may do so for the AGM and any adjournment(s) of it by using the procedures described in the CREST Manual (available from https://www.euroclear.com). CREST Personal Members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf.

In order for a proxy appointment made by means of CREST to be valid, the appropriate CREST message (a 'CREST Proxy Instruction') must be properly authenticated in accordance with Euroclear UK & Ireland Limited's (EUI) specifications and must contain the information required for such instructions, as described in the CREST Manual. The message must be transmitted so as to be received by the issuer's agent (ID: RA19) not later than forty eight hours (disregarding any day that is not a working day) before the time appointed for holding the AGM, being no later than 12 noon on Friday 6 May 2022. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST.

CREST members and, where applicable, their CREST sponsors or voting service providers should note that EUI does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members

and, where applicable, their CREST sponsors or voting service providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.

If you are a person who has been nominated under section 146 of the Act to enjoy information rights, you may have a right under an agreement between you and the member of the Company who has nominated you to have information rights ('Relevant Member') to be appointed or to have someone else appointed as a proxy for the AGM. If you either do not have such a right or if you have such a right but do not wish to exercise it, you may have a right under an agreement between you and the Relevant Member to give instructions to the Relevant Member as to the exercise of voting rights. Your main point of contact in terms of your investment in the Company remains the Relevant Member (or, perhaps, your custodian or broker) and you should continue to contact them (and not the Company) regarding any changes or queries relating to your personal details and your interest in the Company (including any administrative matters). The only exception to this is where the Company expressly requests a response from you. If you are not a member of the Company but you have been nominated by a member of the Company to enjoy information rights under section 146 of the Act, you do not have any right to appoint any proxies under the procedures set out in this notice.
Only those members entered on the Company's register of members no later than 6.30pm on Friday 6 May 2022, or in the case of an adjournment, as at 48 hours (disregarding any day that is not a working day) prior to the time of the adjourned AGM shall be entitled to attend and vote at the AGM in respect of the number of shares registered in their names at that time. Changes to entries on the share register after the relevant deadline will be disregarded in determining the rights of any person to attend or vote at the meeting.
A corporation which is a member can appoint one or more corporate representatives who may exercise, on its behalf, all its powers as a member provided that no more than one corporate representative exercises powers over the same share.
As at 6pm on 1 April 2022 the Company's issued share capital comprised 157,812,000 Ordinary Shares of 25p each. Each Ordinary Share carries the right to one vote at a general meeting of the Company and, therefore, the total number of voting rights in the Company as at 6pm on 1 April 2022 is 157,812,000.
Any member who has a general query about the AGM should contact the Company Secretary by post at the Company's Registered Office. No other method of communication will be accepted. You may not use any electronic address provided in this notice of the AGM or any related documents (including the form of proxy) to communicate with the Company for any purposes other than those expressly stated.
Under Section 527 of the Act a member or members meeting the threshold requirements set out in that section have the right to require the Company to publish on its website a statement setting out any matter that the members propose to raise at the AGM relating to:

(i) the audit of the Company's accounts (including the auditors' report and the conduct of the audit) that are to be laid before the Meeting; or
(ii) any circumstance connected with an auditor of the Company ceasing to hold office since the previous meeting at which annual accounts and reports were laid in accordance with Section 437 of the Act.

The Company may not require the shareholders requesting any such website publication to pay its expenses in complying with Sections 527 or 528 of the Act. Where the Company is required to place a statement on a website under Section 527 of the Act, it must forward the statement to the Company's auditors not later than the time when it makes the statement available on the website.

The business which may be dealt with at the AGM includes any statement that the Company has been required under Section 527 of the Act to publish on a website. The request:

may be in hard copy form which must be signed by you, state your full name and address and sent by post to the Company Secretary at the Company's Registered Office;

Attendance at AGM and proxy voting (continued)

may be in electronic form which must state your full name and address, must be authenticated by the person making it and be sent to [email protected];
must either set out the statement in full or, if supporting a statement sent by another shareholder, clearly identify the statement which is being supported;
must be received by the Company by 4pm on 2 May 2022 which is at least one week before the AGM.
Copies of each Director's service contract and Non-executive Director's terms of appointment with the Company, or with any of its subsidiary undertakings are available for inspection at the registered office of the Company during usual business hours until the time of the AGM and will be available for inspection at the DoubleTree by Hilton Hotel Glasgow Central, 36 Cambridge Street, Glasgow G2 3HN for at least 15 minutes prior to and during the AGM.
Shareholders who prefer to register the appointment of their proxy electronically via the internet can do so through Equiniti's website at www.sharevote.co.uk where full instructions on the procedure are given. The Voting ID, Task ID and Shareholder Reference Number printed on the proxy form will be required in order to use this electronic proxy appointment system. Alternatively shareholders who have already registered with Equiniti's online portfolio service, Shareview, can appoint their proxy electronically by logging on to their portfolio at www.shareview.co.uk and then click on the link to vote. A proxy appointment made electronically will not be valid if received after 12 noon on Friday 6 May 2022.

Appendix 1: Summary of the principal terms of the Macfarlane Group Deferred Bonus Share Plan ('DBSP')

Operation

The Remuneration Committee of the Board of directors of the Company (the 'Committee') will supervise the operation of the DBSP.

Eligibility

Any current or former employee (including an Executive Director) of the Company and any of its subsidiaries will be eligible to participate in the DBSP, at the discretion of the Committee. However, the Committee will make awards under the DBSP only to individuals who may be entitled to receive an annual bonus payment for the preceding financial year of the Company.

Grant of awards

Awards made under the DBSP will be in the form of a deferred right to receive ordinary shares in the Company ('Shares').

The Committee may grant an award in one of two forms:

a) nil or nominal cost options, where a participant can decide when to exercise his/her award over Shares during a limited period of time after it has vested; or
b) a conditional award, where a participant will receive Shares on the vesting of his/her award.

The Committee may normally grant awards within the period of six weeks following: (i) the date of adoption of the DBSP; (ii) the Company's announcement of its results for any period; (iii) a general meeting of the Company; or the lifting of restrictions on dealing in Shares that prevented grant of awards under (i) or (ii). The Committee may also grant awards when there are exceptional circumstances which it considers justifies the granting of awards.

No awards will be granted after the tenth anniversary of the date of adoption of the DBSP.

No payment will be required for the grant of an award. Awards are not transferable (other than to the participant's personal representatives in the event of death). Awards are not pensionable.

Individual limit

The maximum number of Shares that may be awarded to a participant in any financial year will be limited to a proportion of the individual's total annual bonus outcome for the preceding financial year. The proportion of bonus outcome that is deferred into a DBSP award will be determined by the Committee from time to time.

For the duration of the Directors' remuneration policy proposed for approval at the 2022 AGM, 25% of any annual bonus outcomes for Executive Directors will be deferred into awards granted under the DBSP (subject to £10k value 'de minimis' threshold for amounts being deferred).

Overall DBSP limits

The DBSP may operate over new issue Shares, treasury Shares or Shares purchased in the market.

In any ten calendar year period the Company may not issue (or have the possibility to issue) more than:

a) 10% of the issued ordinary share capital of the Company in respect of awards made in that period under the DBSP and any other employees' share scheme adopted by the Company; and
b) 5% of the issued ordinary share capital of the Company in respect of awards made in that period under the DBSP and any other discretionary share plan adopted by the Company.

Treasury Shares will count as new issue Shares for the purposes of these limits but they will also cease to count towards these limits if institutional investor bodies decide that they need not count.

These limits do not include any rights to Shares which have been released or lapsed.

Appendix 1: Summary of the principal terms of the Macfarlane Group Deferred Bonus Share Plan ('DBSP') (continued)

Vesting of awards

Awards will normally vest at the end of a two year period and provided the participant is still an employee in the Company's group (as explained further below).

The Committee may allow awards to be settled in cash (in whole or in part) where it is appropriate to do so.

Leaving employment

If a participant leaves employment with the Company's group in cases of resignation (other than for ill-health, agreed retirement or similar cases as determined by the Committee) or misconduct, his/her unvested award will lapse.

If a participant leaves employment with the Company's group for any other reason he/she will normally retain his/her award which will vest on the normal vesting date with no acceleration of vesting. However, in exceptional cases, the Committee may, at its discretion, permit or require awards to vest at the time of cessation of employment.

On the death of a participant, an unvested award shall vest immediately and an award in the form of an option will be exercisable for a period of 12 months from his/her death.

As is normal for deferred bonus plans, DBSP awards held by a leaver are not subject to pro-rata reductions (the rationale being that the awards have already been subject to performance vesting requirements in the annual bonus year, and the DBSP is accordingly a mechanism for the deferral of part of the achieved annual bonus outcomes).

Corporate events

In the event of a takeover, scheme of arrangement, or winding up of the Company (not being an internal corporate reorganisation), all awards will normally vest early at the time of the event. Awards may also vest on the same basis if a demerger, special dividend or other similar event is proposed which, in the opinion of the Committee, would affect the market price of the Shares to a material extent.

In the event of an internal corporate reorganisation, awards may be replaced by equivalent new awards over shares in a new holding company.

In the event of a corporate event leading to a change of control of the Company (not being an internal corporate reorganisation), the Committee may decide that subsisting awards are surrendered in consideration for the grant of an equivalent award over shares in the acquiring company.

Participants' rights

DBSP awards will not confer any shareholder rights on participants until the awards have vested and the participants have received their Shares.

The number of Shares comprised in a DBSP award will be increased in respect of an amount equivalent to the dividends that would have been paid on the Shares vesting under the award between the date of grant and the date the award vests (and assuming reinvestment in Shares on the relevant ex-dividend dates).

In exceptional circumstances only, the Committee may determine that any additional Shares in respect of dividends that would have been paid on the Shares vesting under the awards, can instead be paid in cash.

Rights attaching to Shares

Any Shares allotted when an award vests (or for an award structured as an option, when it is exercised) will rank equally with all other Shares then in issue (except for rights arising by reference to a record date prior to their allotment).

Variation of capital

In the event of any variation of the Company's share capital, or in the event of a demerger, special dividend or other event having a material impact on the value of the Shares, the Committee may make such adjustments as it considers appropriate to the definition of Shares, number of Shares subject to a DBSP award, or the option price (if any).

Malus and clawback

The Committee retains a power to recoup the value of unvested and previously vested awards from an individual either before vesting or within a period of 2 years from the date of grant of an award, if it considers it appropriate to do so. The Committee may choose to exercise this power in the following circumstances:

a material misstatement of financial results of any company in the Company's group;
the extent to which any performance condition, relating to an annual bonus to which a DBSP award relates, was satisfied was based on an error, or on inaccurate or misleading information;
circumstances arose which would have warranted the summary dismissal of the participant (whether or not the participant was dismissed).

Alterations to the DBSP

The Committee may, at any time, alter the provisions of the DBSP in any respect, provided that the prior approval of shareholders must be obtained for any alterations that are in respect of the rules governing eligibility, limits on participation, the overall limits on the issue of Shares or the transfer of Shares held in treasury, the basis for determining a participant's entitlement to, and the terms of, the Shares or cash to be provided under the DBSP and the adjustment of awards.

The requirement to obtain the prior approval of shareholders will not, however, apply to any minor alteration made to benefit the administration of the DBSP, to take account of a change in legislation or to obtain or maintain favourable tax, exchange control or regulatory treatment for participants or for any company in the Company's group.

If the proposed alterations are to the material disadvantage of participants the Committee must invite participants to indicate if they approve the alterations and if so the alterations must be approved by a majority of the participants that respond.

Overseas plans

The Committee may at any time, without further shareholder approval, establish further plans in overseas territories, any such plan to be similar to the DBSP, but modified to take account of local tax, exchange control or securities laws.

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

AI assistant

MACFARLANE GROUP PLC Proxy Solicitation & Information Statement 2022

4664_agm-r_2022-04-05_791d51d7-d6c3-4c99-982e-db8870a8284e.pdf

Notice of Annual General Meeting

Ordinary Business

Special Business

Notice of Annual General Meeting (continued)

Explanation of the Resolutions to be proposed at the AGM

Explanation of the Resolutions to be proposed at the AGM (continued)

Attendance at AGM and proxy voting

Attendance at AGM and proxy voting (continued)

Operation

Eligibility

Grant of awards

Individual limit

Overall DBSP limits

Vesting of awards

Leaving employment

Corporate events

Participants' rights

Rights attaching to Shares

Variation of capital

Malus and clawback

Alterations to the DBSP

Overseas plans

AI assistant

MACFARLANE GROUP PLC — Proxy Solicitation & Information Statement 2022

4664_agm-r_2022-04-05_791d51d7-d6c3-4c99-982e-db8870a8284e.pdf

Notice of Annual General Meeting

Ordinary Business

Special Business

Notice of Annual General Meeting (continued)

Explanation of the Resolutions to be proposed at the AGM

Explanation of the Resolutions to be proposed at the AGM (continued)

Attendance at AGM and proxy voting

Attendance at AGM and proxy voting (continued)

Operation

Eligibility

Grant of awards

Individual limit

Overall DBSP limits

Vesting of awards

Leaving employment

Corporate events

Participants' rights

Rights attaching to Shares

Variation of capital

Malus and clawback

Alterations to the DBSP

Overseas plans

More from MACFARLANE GROUP PLC

MACFARLANE GROUP PLC Proxy Solicitation & Information Statement 2022